What Happened
The pharmacist who owned and operated Summit Pharmacy of Iowa in Fairfield diverted thousands of prescription pills from his own pharmacy for personal use over roughly a year and a half.
From June 2022 to at least November 2023, the pharmacist obtained prescription pills from his own pharmacy for personal use in three ways: he ordered pills and did not report them in the pharmacy's inventory, he took pills directly from pharmacy stock, and he took pills from the pharmacy's controlled-substance take-back collection bin. In total, he obtained more than 3,500 oxycodone and hydrocodone pills — both Schedule II controlled substances — and more than 400 carisoprodol pills, a Schedule IV muscle relaxant.
He was sentenced on July 28, 2025 to four years of probation and ordered to pay a $9,500 fine. DEA Diversion Investigators uncovered the diversion during a review of the pharmacy's operations.
What Went Wrong
The pharmacy's own owner exploited three separate channels — unreported ordering, direct stock theft, and the take-back bin — to divert controlled substances. Key failure points:
- Owner-level ordering was not independently verified. As the pharmacy's owner and operator, he could place orders and simply not enter them into inventory, with no second party cross-checking supplier invoices against recorded stock.
- The controlled-substance take-back bin was not secured or monitored. Collection bins intended for public medication disposal became a diversion source, indicating the bin's contents were not tracked, weighed, or witnessed at destruction.
- Ownership created a lack of internal oversight. Small independent pharmacies often lack the separation of duties that catches an owner's own diversion, since the person who would normally supervise staff was the one diverting.
- Pattern persisted for roughly 18 months. The scale of diversion — thousands of pills across three methods — suggests no routine controlled-substance audit caught the discrepancy before DEA investigators did.
How It Could Have Been Prevented
- Require an independent third party — an accountant, consultant pharmacist, or corporate compliance officer — to periodically audit an owner-operator's own ordering and inventory records.
- Secure, weigh, and log all controlled-substance take-back bin contents, with witnessed destruction under DEA Form 41 procedures.
- Reconcile supplier invoices and DEA Form 222/CSOS orders directly against recorded inventory on a routine schedule, independent of who placed the order.
- Use DEA ARCOS and state PDMP reporting discrepancies as an early warning signal for ordering that outpaces documented dispensing.
- For single-pharmacist or owner-operated pharmacies, engage a corporate or franchise compliance program that includes outside audits.
Related Guidance
- Pharmacy Self-Assessment Checklist — Pharmacy-specific self-assessment covering ownership and staff controls.
- DEA Form 41 Destruction Guide — Requirements for witnessed destruction of controlled substances, including take-back bin contents.
- CSOS Electronic Ordering Guide — Controlled substance ordering system requirements and audit trail.
- Controlled Substance Inventory Guide — Reconciliation, cycle counts, and biennial inventory requirements.
- 15 Red Flags of Drug Diversion — Behavioral and recordkeeping indicators of diversion by pharmacy staff and owners.